At Main Line Health, we believe that research is essential for advancing health care, leading to medical breakthroughs that improve and save lives. Our goal is to rapidly translate research findings into clinical care that benefits our patients.
Learn more about our research initiatives
Lankenau Institute for Medical Research (LIMR)
Founded in 1927, Lankenau Institute for Medical Research (LIMR) is one of only a few hospital-associated biomedical research centers in the United States. As the research center for Main Line Health, which serves the Philadelphia region and elsewhere, LIMR conducts laboratory-based and clinical investigations in a tightly knit, multidisciplinary community of scientists, nurses and physicians.
Learn more by visiting limr.org
Clinical Trials
At Main Line Health, our patients come first. Part of that commitment is conducting clinical research aimed at helping them live longer, healthier lives.
A clinical trial is a research study that tests the safety and effectiveness of treatments on patients for various health conditions. Studies may test new medications, diagnostic tools or medical devices. Our research teams offer trials for cancer, cardiac and other conditions, giving Main Line Health patients the opportunity to try new and cutting-edge treatments while helping to advance medical knowledge that can benefit future patients.
Learn more about clinical trials at Main Line Health
Institutional Review Board
The Office of Research Affairs (ORA) is structured to facilitate the review process of human subject research by the MLH IRB. We are a resource for navigating the realm of regulatory compliance and fostering the ethical conduct of human subject research within the MLHS research community at large.
Learn more about our institutional review board
Sharpe-Strumia Research Foundation of Bryn Mawr Hospital
The mission of the Sharpe-Strumia Research Foundation is to encourage and support the conduct of medical research by practicing physicians on the medical staff of Main Line Hospitals with preference given to physicians whose primary hospital affiliation is the Bryn Mawr Campus, and to research which relates to identified clinical initiatives at the Bryn Mawr campus and Main Line Hospitals.